Ethnicity/race, use of pharmacotherapy, scope of physician-ordered cholesterol screening, and provision of diet/nutrition or exercise counseling during US office-based visits by patients with hyperlipidemia
- PMID: 20334447
- DOI: 10.2165/11532820-000000000-00000
Ethnicity/race, use of pharmacotherapy, scope of physician-ordered cholesterol screening, and provision of diet/nutrition or exercise counseling during US office-based visits by patients with hyperlipidemia
Abstract
Background: Elevation of serum cholesterol, or hyperlipidemia, is recognized as one of the major modifiable risk factors in the development of atherosclerosis and cardiovascular disease. On a US population basis, there has been a downward trend in total- and LDL-cholesterol levels, and an increase in cholesterol screening. Nevertheless, previous research suggests that there remain racial/ethnic disparities in the access to and quality of care for hyperlipidemia.
Objective: The aim of this study was to examine the extent of racial/ethnic disparities in the provision of pharmacotherapy, cholesterol screening and diet/nutrition or exercise counseling during US office-based physician-patient encounters (visits) by patients with hyperlipidemia.
Methods: We examined data from the 2005 US National Ambulatory Medical Care Survey for office-based visits for hyperlipidemia for patients aged > or =20 years in terms of prescribing for hyperlipidemia, and the ordering/provision of cholesterol testing, diet/nutrition counseling, and exercise counseling.
Results: Use of pharmacotherapy for hyperlipidemia varied by ethnicity/race (chi2, p < 0.05). Physician-ordered/provided cholesterol screening occurred in 44.2% of all office-based visits; 46.5% for Whites, 35.4% for Blacks, and 30.3% for Hispanics (chi2, p < 0.05). Diet/nutrition counseling was ordered/provided in 39.7% of office-based visits; 40.4% for Whites, 32.6% for Blacks, and 39.0% for Hispanics (chi2, p < 0.05). Exercise counseling was ordered/provided in 32.1% of office-based visits; 32.7% for Whites, 27.2% for Blacks, and 30.6% for Hispanics (chi2, p < 0.05).
Conclusions: These findings reveal a disparity in use of pharmacotherapy for hyperlipidemia, physician-ordered/provided cholesterol screening, diet/nutrition counseling, and exercise counseling by ethnicity/race. Further research is required to discern, in greater detail, reasons for the observed differences reported, and to ensure equitable access to established standards of care.
Similar articles
-
Diagnosis of depression and use of antidepressant pharmacotherapy among adults in the United States: does a disparity persist by ethnicity/race?Clin Drug Investig. 2012 Feb 1;32(2):139-44. doi: 10.2165/11598950-000000000-00000. Clin Drug Investig. 2012. PMID: 22220929
-
Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits.Am J Cardiovasc Drugs. 2018 Feb;18(1):65-71. doi: 10.1007/s40256-017-0247-y. Am J Cardiovasc Drugs. 2018. PMID: 28849367
-
Racial and ethnic differences in pediatric obesity-prevention counseling: national prevalence of clinician practices.Obesity (Silver Spring). 2008 Mar;16(3):690-4. doi: 10.1038/oby.2007.78. Epub 2008 Jan 17. Obesity (Silver Spring). 2008. PMID: 18239563
-
Disparities in utilization of coronary artery disease treatment by gender, race, and ethnicity: opportunities for prevention.J Natl Black Nurses Assoc. 2007 Jul;18(1):36-49. J Natl Black Nurses Assoc. 2007. PMID: 17679413 Review.
-
Physician Office Visits That Included Complementary Health Approaches in U.S. Adults: 2005-2015.J Integr Complement Med. 2022 Aug;28(8):641-650. doi: 10.1089/jicm.2021.0331. Epub 2022 May 13. J Integr Complement Med. 2022. PMID: 35559729 Free PMC article. Review.
Cited by
-
Lack of Lipid Screening Disparities in Obese Latino Adults at Health Centers.Am J Prev Med. 2017 Jun;52(6):805-809. doi: 10.1016/j.amepre.2016.12.020. Epub 2017 Feb 9. Am J Prev Med. 2017. PMID: 28190691 Free PMC article.
-
Race-sex differences in the management of hyperlipidemia: the REasons for Geographic and Racial Differences in Stroke study.Am J Prev Med. 2015 May;48(5):520-7. doi: 10.1016/j.amepre.2014.10.025. Am J Prev Med. 2015. PMID: 25891050 Free PMC article.
-
A retrospective cohort study of the potency of lipid-lowering therapy and race-gender differences in LDL cholesterol control.BMC Cardiovasc Disord. 2011 Sep 30;11:58. doi: 10.1186/1471-2261-11-58. BMC Cardiovasc Disord. 2011. PMID: 21961563 Free PMC article.
-
Telehealth Trials to Address Health Equity in Stroke Survivors.Stroke. 2023 Feb;54(2):396-406. doi: 10.1161/STROKEAHA.122.039566. Epub 2023 Jan 23. Stroke. 2023. PMID: 36689591 Free PMC article. Review.
-
Relationship of Lifestyle Medical Advice and Non-HDL Cholesterol Control of a Nationally Representative US Sample with Hypercholesterolemia by Race/Ethnicity.Cholesterol. 2012;2012:916816. doi: 10.1155/2012/916816. Epub 2012 Oct 15. Cholesterol. 2012. PMID: 23119150 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical